GARM II: A Study on the Genetics of Age-related Maculopathy

RECRUITING

Description:  Dr. Michael Gorin at Jules Stein Eye Institute at UCLA is conducting a nationwide study of genetic and other risk factors that contribute to the development of age-related macular degeneration (also known as Age-Related Maculopathy). Affected individuals and family members may be eligible to participate in this observational study (this is not a treatment trial), which does not require travel to UCLA. Study participants will complete questionnaires through a confidential and secure website.

Trial Status:  Recruiting participants

Partial List of Eligibility Criteria: 

1. Individuals from 49 to 65 years old who have/had at least one parent with macular degeneration. Spouses or partners from 49 to 65 years old can also be included in the study.
   
2. Age-Related Macular degeneration affected individuals with adult children ranging in age from 49 to 65 years old who are willing to participate in the study.

Clinical Trial Contact:
For more information, please call or email the GARM Study center at: 1-800-286-8581 or This e-mail address is being protected from spambots. You need JavaScript enabled to view it

You can go to the GARM II website and read about the study with complete anonymity.  www.jsei.org/garm

Additional Information: 
GARM II listing on ClinicalTrials.gov